Literature DB >> 9668329

Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60.

G Slesak1, A Melms, F Gerneth, N Sommer, R Weissert, J Dichgans.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9668329     DOI： 10.1111/j.1749-6632.1998.tb11017.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  Dysphonia as first symptom of late-onset myasthenia gravis.

Authors:  Manuel Montero-Odasso
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

2.  Characteristics of late-onset myasthenia gravis.

Authors:  Saša A Zivković; Paula R Clemens; David Lacomis
Journal:  J Neurol       Date:  2012-04-05       Impact factor: 4.849

3.  Statin-associated weakness in myasthenia gravis: a case report.

Authors:  Michael J Keogh; John M Findlay; Simon Leach; John Bowen
Journal:  J Med Case Rep       Date:  2010-02-20

4.  Intermittent weakness and mediastinal weakening.

Authors:  Umer Feroze Malik; Mersadies R Martin; Hien D Pham; Ahmed Mahmoud; Sheela Kapre
Journal:  Mcgill J Med       Date:  2009-11-16

5.  Evidence of underdiagnosis of myasthenia gravis in older people.

Authors:  A Vincent; L Clover; C Buckley; J Grimley Evans; P M Rothwell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

Review 6.  Treatment of Myasthenia Gravis in the Aged.

Authors:  Nuha M Alkhawajah; Joel Oger
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

7.  Myasthenia gravis: MuSK MG, late-onset MG and ocular MG.

Authors:  Feza Deymeer
Journal:  Acta Myol       Date:  2020-12-01

8.  Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset.

Authors:  Sijia Zhao; Xu Yan; Jiaqi Ding; Kaixi Ren; Shuyu Sun; Jiarui Lu; Chao Zhang; Kai Zhang; Zhuyi Li; Jun Guo
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.086

Review 9.  Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

Authors:  Nico Melzer; Tobias Ruck; Peter Fuhr; Ralf Gold; Reinhard Hohlfeld; Alexander Marx; Arthur Melms; Björn Tackenberg; Berthold Schalke; Christiane Schneider-Gold; Fritz Zimprich; Sven G Meuth; Heinz Wiendl
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.